MiraKind
MiraKind
Los Angeles, California, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, autoimmune disease, breast disorder, breast neoplasm, cancer, endocrine system disorder, endometriosis, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, immune system disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, skin disorder | Recruiting | Not stated | 2025-01-23 | NCT02253251 |